Carcinoid Tumor,Gastrointestinal Clinical Trials

• FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00084461 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Sorafenib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00131911 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00075439 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00027638 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00093782 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00002470 - Completed
  metastatic gastrointestinal carcinoid tumor; recurrent gastrointestinal carcinoid tumor; pulmonary carcinoid tumor
  
• Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00055809 - Completed
  recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
  
• BB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00074256 - Recruiting
  adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ...
  
• Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00454376 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neoplastic Syndrome
  
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
  ClinicalTrials.gov Identifier: NCT00412061 - Recruiting
  Carcinoid Tumor; Malignant Carcinoid Syndrome
  
• Flavopiridol in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00112684 - Recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; Pheochromocytoma; Thyroid Cancer
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416767 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00466856 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Metastatic Cancer; Neoplastic Syndrome; Pheochromocytoma
  
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227773 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
  
• AMG 706 in Treating Patients With Low-Grade Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00427349 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227617 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Carcinoma of the Skin
  
• Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
  ClinicalTrials.gov Identifier: NCT00454363 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Neoplastic Syndrome
  
• Study of SU011248 in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00056693 - Active, not recruiting
  Neuroendocrine Tumor; Carcinoid Tumor
  
• A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00328497 - Active, not recruiting
  Carcinoid Tumor
  
• Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00009906 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436735 - Recruiting
  Colorectal Cancer; Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neuroendocrine Carcinoma of the Skin; Ovarian Cancer; Pheochromocytoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Study Of Su011248 Administered In A Daily Regimen In Patients With Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00137449 - Active, not recruiting
  Gastrointestinal Stromal Tumor
  
• SU011248 in Treating Patients With Malignant Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00085618 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Temozolomide in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00005597 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00025246 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00041197 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00017199 - Completed
  miscellaneous islet cell cancer; Gastrinoma; Insulinoma; Somatostatinoma; Glucagonoma; metastatic gastrointestinal carcinoid tumor
  
• Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed On or After Previous Treatment With Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00265798 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Study Comparing 12 Months versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
  ClinicalTrials.gov Identifier: NCT00116935 - Recruiting
  Sarcoma; Gastrointestinal Stromal Tumor
  
• SU011248 in Patients with Malignant Gastrointestinal Stromal Tumor (GIST) That Have Progressed During or Not Tolerated Treatment with Imatinib Mesylate (GLEEVEC™)
  ClinicalTrials.gov Identifier: NCT00075218 - Active, not recruiting
  Gastrointestinal Neoplasms
  
• Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00028002 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00103168 - Recruiting
  gastrointestinal stromal tumor
  
• Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00091078 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00112632 - Recruiting
  gastrointestinal stromal tumor
  
• Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
  ClinicalTrials.gov Identifier: NCT00069940 - Active, not recruiting
  Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer
  
• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• Study Evaluating SOM230 in Patients with Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00088595 - Active, not recruiting
  Carcinoid Tumors
  
• A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)
  ClinicalTrials.gov Identifier: NCT00457743 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00324987 - Not yet recruiting
  Gastrointestinal Stromal Tumor
  
• A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor (GIST) who May Derive Benefit from Treatment with SU011248
  ClinicalTrials.gov Identifier: NCT00094029 - Recruiting
  Gastrointestinal Neoplasm
  
• Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00254267 - Active, not recruiting
  Advanced Gastrointestinal Stromal Tumor
  
• BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00346385 - Suspended
  Cervical Cancer; Gastrointestinal Carcinoid Tumor; Lung Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049023 - Recruiting
  Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma
  
• NGR-TNF in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00098943 - Active, not recruiting
  adult solid tumor; Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; kidney and urinary cancer
  
• Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00372567 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00041249 - Active, not recruiting
  adult soft tissue sarcoma; gastrointestinal stromal tumor
  
• Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
  ClinicalTrials.gov Identifier: NCT00290485 - Recruiting
  Gastrointestinal Stromal Tumors
  
• Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00568750 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00573404 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00024076 - Active, not recruiting
  lung metastases; malignant mesothelioma; Non-small cell lung cancer; pulmonary carcinoid tumor; Small Cell Lung Cancer; thymoma and thymic carcinoma
  
• Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
  ClinicalTrials.gov Identifier: NCT00033605 - Active, not recruiting
  adult solid tumor; Diarrhea; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; male reproductive cancer
  
• BCX-1777 in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00073944 - Active, not recruiting
  central nervous system cancer; female reproductive cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer; skin tumor
  
• Study of AMG 706 in Subjects with Advanced Gastrointestinal Stromal Tumors (GISTs)
  ClinicalTrials.gov Identifier: NCT00089960 - Active, not recruiting
  Gastrointestinal Cancer
  
• Pharmacogenetics of Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00190255 - Active, not recruiting
  Gastrointestinal Hemorrhage; Stomach Ulcer; Anti-Inflammatory Agents, Non-Steroidal
  
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Abdominal Cancer
  ClinicalTrials.gov Identifier: NCT00436657 - Recruiting
  Peritoneal Neoplasms; Retroperitoneal Neoplasms; Gastrointestinal Neoplasms; Adenocarcinoma; Neuroblastoma; Ovarian Neoplasms; Sarcoma; Adrenocortical Carcinoma; Wilms Tumor; Rhabdomyosarcoma; Desmoplastic Small Round Cell Tumor
  
• Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-Line Treatment)
  ClinicalTrials.gov Identifier: NCT00289445 - Active, not recruiting
  Gastrointestinal Neoplasms; Neoplasm Metastasis
  
• Bone Marrow-Derived Cells' Contribution to Tumor Formation and Inflammation
  ClinicalTrials.gov Identifier: NCT00452205 - Recruiting
  Gastrointestinal Neoplasms
  
• Doxorubicin and Flavopiridol in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00098579 - Recruiting
  gastrointestinal stromal tumor; recurrent adult soft tissue sarcoma; stage IV adult soft tissue sarcoma
  
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00005049 - Active, not recruiting
  female reproductive cancer; Gastrointestinal Cancer; unclassified and other cancer
  
• Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
  ClinicalTrials.gov Identifier: NCT00258180 - Recruiting
  Diarrhea; Gastrointestinal Complications; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
  ClinicalTrials.gov Identifier: NCT00171977 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Open-Label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00293124 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00087074 - Active, not recruiting
  recurrent adult soft tissue sarcoma; stage I adult soft tissue sarcoma; stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma; ...
  
• Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00402259 - Recruiting
  Gastrointestinal Hemorrhage
  
• A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
  ClinicalTrials.gov Identifier: NCT00570635 - Recruiting
  Gastrointestinal Stromal Tumors; Gastrointestinal Neoplasms
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003704 - Active, not recruiting
  Gastrointestinal Cancer; Reproductive Cancers
  
• Effect of Oral Nutritional Supplements With Specialized Nutrients on Functional Recovery and Morbidity After Gastrointestinal Surgery
  ClinicalTrials.gov Identifier: NCT00546975 - Recruiting
  Patients Following Gastrointestinal Surgery
  
• Endoscopic Stenting of Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00422409 - Recruiting
  Gastrointestinal Neoplasms; Biliary Tract Neoplasms
  
• Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
  ClinicalTrials.gov Identifier: NCT00539318 - Recruiting
  Gastrointestinal Cancer
  
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00012246 - Completed
  Gastrointestinal Cancer
  
• Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
  ClinicalTrials.gov Identifier: NCT00436774 - Recruiting
  Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Gastrointestinal Complications; Long-Term Effects Secondary to Cancer Therapy in Children; Neurotoxicity; Ovarian Cancer; Pulmonary Complications; Sexual Dysfunction and Infertility; Sexuality and Reproductive Issues; Urinary Complications
  
• Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
  ClinicalTrials.gov Identifier: NCT00005955 - Active, not recruiting
  childhood brain tumor; childhood nerve tumor
  
• Phase I Study of Imatinib Mesylate and SU011248 (Sunitinib) for Patients With GIST
  ClinicalTrials.gov Identifier: NCT00495001 - Not yet recruiting
  Gastrointestinal Stromal Tumor; GIST
  
• Genetic Study of Patients and Families With a History of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003648 - Active, not recruiting
  Colon Cancer; Gastrointestinal Cancer; Rectal Cancer
  
• Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00401908 - Recruiting
  Acute Gastrointestinal Bleeding; Acute Coronary Syndrome
  
• Treatment for Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00052962 - Recruiting
  Gastrointestinal Neoplasm
  
• Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
  ClinicalTrials.gov Identifier: NCT00005790 - Active, not recruiting
  genetic condition; Cancer; adult brain tumor; Brain Tumor; stage/type, adult brain tumor; body system/site cancer; central nervous system cancer; ...
  
• Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00353015 - Recruiting
  Gastrointestinal Cancer; Carcinoma, Neuroendocrine
  
• Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00510354 - Recruiting
  Progressive Gastrointestinal Stromal Tumor
  
• The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients with HIV
  ClinicalTrials.gov Identifier: NCT00001034 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections; Gastrointestinal Diseases
  
• A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing c-Kit Gene
  ClinicalTrials.gov Identifier: NCT00237185 - Completed
  Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
  
• Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
  ClinicalTrials.gov Identifier: NCT00230217 - Active, not recruiting
  Tumors; Hyperuricemia; Tumor Lysis Syndrome
  
• Humanized anti-IL-2 receptor monoclonal antibody in moderate-to-severe ulcerative colitis
  ClinicalTrials.gov Identifier: NCT00073047 - Active, not recruiting
  Ulcerative Colitis; Gastrointestinal Disease; Inflammatory Bowel Disease
  
• Study of Rasburicase Versus Allopurinol in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome
  ClinicalTrials.gov Identifier: NCT00230178 - Active, not recruiting
  Tumor Lysis Syndrome; Cancer; Hyperuricemia
  
• Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
  ClinicalTrials.gov Identifier: NCT00006342 - Active, not recruiting
  Lymphoma; Brain Tumor
  
• HDUPE 2004: Gastro-Oesophageal Haemorrhage in Emergency : Gastric Préparation to Endoscopy.
  ClinicalTrials.gov Identifier: NCT00259220 - Recruiting
  Upper Gastrointestinal Bleeding
  
• Capsule Endoscopy or Mesenteric Angiogram in Patients with Overt GIB of Obscure Origin
  ClinicalTrials.gov Identifier: NCT00153686 - Recruiting
  Gastrointestinal Hemorrhage
  
• Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
  ClinicalTrials.gov Identifier: NCT00003804 - Active, not recruiting
  stage I Wilms' tumor
  
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008086 - Active, not recruiting
  Brain Tumor; Genetic Condition; Solid Tumor
  
• Bevacizumab in Combination with Temozolomide in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00137774 - Active, not recruiting
  Metastatic Neuroendocrine Tumor; Neuroendocrine Tumor
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
  ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
  Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
  
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
  ClinicalTrials.gov Identifier: NCT00003548 - Active, not recruiting
  Gastrointestinal Cancer; Pancreatic Cancer; Liver Cancer; Female Reproductive Cancer
  
• High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00002722 - Active, not recruiting
  childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
  
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00025415 - Completed
  adult solid tumor; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003852 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; pediatric germ cell tumor; extragonadal germ cell tumor
  
• Tumor Cell Vaccine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002505 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
  ClinicalTrials.gov Identifier: NCT00019565 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00452946 - Recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Complications; Liver Cancer; Pancreatic Cancer; Radiation Toxicity